Effect of metabotropic glutamate receptor 3 genotype on N-acetylaspartate levels and neurocognition in non-smoking, active alcoholics

Behavioral and Brain Functions

Yan Xia²  Dongying Ma¹  Jian Hu²  Chunling Tang²  Zheng Wu²  Lei Liu²  Feng Xin² 

[1] Department of Neurosurgery, 2nd Affiliated Hospital of Harbin Medical University, 246 Xuefu Road, Harbin, Heilongjiang Province, 150086, PR China

[2] Mental Health Institute, Mental Health Centre, 1st Affiliated Hospital of Harbin Medical University, 23 Youzheng Street, Harbin, Heilongjiang Province, 150001, PR China

关键词: Executive function;    N-acetylaspartate;    Single nucleotide polymorphism;    Metabotropic glutamate receptor 3;    Alcohol dependence;   

Others  :  794067
DOI  :  10.1186/1744-9081-8-42

 received in 2011-12-04, accepted in 2012-08-16,  发布年份 2012

【 摘 要 】

Background

We studied the effects of single nucleotide polymorphisms (SNPs) in the metabotropic glutamate receptor 3 (GRM3) gene on brain N-acetylaspartate (NAA) concentrations and executive function (EF) skills in non-smoking, active alcoholics, and evaluated associations between these variables.

Methods

SNPs (rs6465084, rs1468412, and rs2299225) in GRM3 were genotyped in 49 male, non-smoking, alcohol-dependent patients and 45 healthy control subjects using ligase detection reactions. NAA/creatine (Cr) ratios in left prefrontal gray matter (GM) and white matter (WM), left parietal GM, left parietal WM, and cerebellar vermis regions were measured by Proton ¹ H Magnetic resonance spectroscopy (MRS). EF was measured by the Wisconsin Card Sorting Test (WCST).

Results

Compared to controls, alcoholics had lower NAA/Cr ratios in prefrontal GM and WM regions and performed more poorly on all EF tests (P < 0.001). Alcoholics with the A/A genotype for SNP rs6465084 had lower NAA/Cr ratios in prefrontal GM and WM regions and had poorer EF skills than alcoholics who were G-carriers for this SNP (P < 0.01). Non-alcoholics with the A/A genotype for rs6465084 also had lower NAA/Cr levels in prefrontal GM and made more random errors in the WCST than G-carriers (P < 0.01). The A/A genotype group for SNP rs6465084 was significantly different from the G carriers for the variables of NAA/Cr ratios and WCST scores in both alcoholics and controls (P < 0.05). Alcoholics who were T-carriers for rs1468412 had lower NAA/Cr ratios in prefrontal GM and showed poorer EF skills (P < 0.05). No effects of rs2299225 genotype on NAA/Cr or executive skills were observed. NAA/Cr in left prefrontal regions correlated with certain parameters of EF testing in both alcoholics and controls (P < 0.05), but the significance of this correlation among alcoholics disappeared after adjustment for the effects of genotype.

Conclusions

Our results provide evidence that glutamate system dysfunction may play a role in the prefrontal functional abnormalities seen in alcohol dependence. It is possible that certain GRM3 SNP genotypes (the A/A genotype of rs6465084 and the T allele of rs1468412) may further lower NAA/Cr levels and EF skills in addition to the effect of alcohol.

【 授权许可】

   
2012 Xia et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Harper C: The neurotoxicity of alcohol. Hum Exp Toxicol 2007, 26:251-257.
• [2]Harper C: The neuropathology of alcohol-related brain damage. Alcohol & Alcohol 2009, 44:136-140.
• [3]Ceballos NA: Tobacco use, alcohol dependence, and cognitive performance. J Gen Psychol 2006, 133:375-388.
• [4]Mayfield RD, Harris RA, Schuckit MA: Genetic factors influencing alcohol dependence. Br J Pharmacol 2008, 15:275-287.
• [5]Ducci F, Goldman D: Genetic approaches to addiction: genes and alcohol. Addiction 2008, 103:1414-1428.
• [6]Melendez RI, Hicks MP, Cagle SS, Kalivas PW: Ethanol exposure decreases glutamate uptake in the nucleus accumbens. Alcohol Clin Exp Res 2005, 29:326-333.
• [7]Vengeliene V, Bilbao A, Molander A, Spanagel R: Neuropharmacology of alcohol addiction. Br J Pharmacol 2008, 154:299-315.
• [8]Bishop JR, Ellingrod VL, Moline J, Miller D: Association between the polymorphic GRM3 gene and negative symptom improvement during olanzapine treatment. Schizophr Res 2005, 77:253-260.
• [9]Holden C: Excited by glutamate. Science 2003, 300:1866-1868.
• [10]Schoepp DD: Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system. J Pharmacol Exp Ther 2001, 299:12-20.
• [11]Chen Q, He G, Chen Q, Wu S, Xu Y, Feng G, Li Y, Wang L, He L: A case–control study of the relationship between the metabotropic glutamate receptor 3 gene and schizophrenia in the Chinese population. Schizophr Res 2005, 73:21-26.
• [12]Scherer SW, Duvoisin RM, Kuhn R, Heng HH, Belloni E, Tsui LC: Localization of two metabotropic glutamate receptor genes, GRM3 and GRM8, to human chromosome 7q. Genomics 1996, 31:230-233.
• [13]Egan MF, Straub RE, Goldberg TE, Yakub I, Callicott JH, Hariri AR, Mattay VS, Bertolino A, Hyde TM, Shannon-Weickert C, Akil M, Crook J, Vakkalanka RK, Balkissoon R, Gibbs RA, Kleinman JE, Weinberger DR: Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia. Proc Natl Acad Sci USA 2004, 101:12604-12609.
• [14]Marenco S, Steele SU, Egan MF, Goldberg TE, Straub RE, Sharrief AZ, Weinberger DR: Effect of metabotropic glutamate receptor 3 genotype on N-acetylaspartate measures in the dorsolateral prefrontal cortex. Am J Psychiatry 2006, 163:740-742.
• [15]Fujii Y, Shibata H, Kikuta R, Makino C, Tani A, Hirata N, Shibata A, Ninomiya H, Tashiro N, Fukumaki Y: Positive associations of polymorphisms in the metabotropic glutamate receptor type 3 gene (GRM3) with schizophrenia. Psychiatr Genet 2003, 13:71-76.
• [16]Bäckström P, Hyytiä P: Suppression of alcohol self-administration and cue-induced reinstatement of alcohol seeking by the mGlu2/3 receptor agonist LY379268 and the mGlu8 receptor agonist (S)-3,4-DCPG. Eur J Pharmaco 2005, 528:110-118.
• [17]Bossert JM, Liu SY, Lu L, Shaham Y: A role of ventral tegmental area glutamate in contextual cue-induced relapse to heroin seeking. J Neurosci 2004, 24:10726-10730.
• [18]Rodd ZA, McKinzie DL, Bell RL, McQueen VK, Murphy JM, Schoepp DD, McBride WJ: The metabotropic glutamate 2/3 receptor agonist LY404039 reduces alcohol-seeking but not alcohol self-administration in alcohol-preferring (P) rats. Behav Brain Res 2006, 71:207-215.
• [19]Worst TJ, Tan JC, Robertson DJ, Freeman WM, Hyytia P, Kiianmaa K, Vrana KE: Transcriptome analysis of frontal cortex in alcohol-preferring and nonpreferring rats. J Neurosci Res 2005, 80:529-538.
• [20]Zhao Y, Dayas CV, Aujla H, Baptista MA, Martin-Fardon R, Weiss F: Activation of group II metabotropic glutamate receptors attenuates both stress and cue-induced ethanol-seeking and modulates c-fos Expression in the hippocampus and amygdala. J Neurosci 2006, 26:9967-9974.
• [21]Sidhpura N, Weiss F, Martin-Fardon R: Effects of the mGlu2/3 agonist LY379268 and the mGlu5 antagonist MTEP on ethanol seeking and reinforcement are differentially altered in rats with a history of ethanol dependence. Biol Psychiatry 2010, 67:804-811.
• [22]Meyerhoff DJ, Blumenfeld R, Truran D, Lindgren J, Flenniken D, Cardenas V, Chao LL, Rothlind J, Studholme C, Weiner H: Effects of heavy drinking, binge drinking, and family history of alcoholism on regional brain metabolites. Alcohol Clin Exp Res 2004, 28:650-661.
• [23]Durazzo TC, Gazdzinski S, Banys P, Meyerhoff DJ: Cigarette smoking exacerbates chronic alcohol-induced brain damage: a preliminary metabolite imaging study. Alcohol Clin Exp Res 2004, 28:1849-1860.
• [24]Durazzo TC, Gazdzinski S, Banys P, Meyerhoff DJ: Brain metabolite concentrations and neurocognition during short-term recovery from alcohol dependence: Preliminary evidence of the effects of concurrent chronic cigarette smoking. Alcohol Clin Exp Res 2006, 30:539-551.
• [25]Durazzo TC, Gazdzinski S, Meyerhoff DJ: The neurobiological and neurocognitive consequences of chronic cigarette smoking in alcohol use disorders. Alcohol & Alcohol 2007, 42:174-185.
• [26]Meyerhoff DJ, Durazzo TC: Proton magnetic resonance spectroscopy in alcohol use disorders: a potential new endophenotype? Alcohol Clin Exp Res 2008, 32:1146-1158.
• [27]Simmons ML, Frondoza CG, Coyle JT: Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience 1991, 45:37-45.
• [28]Vion-Dury J, Meyerhoff DJ, Cozzone PJ, Weiner MW: What might be the impact on neurology of the analysis of brain metabolism by in vivo magnetic resonance spectroscopy? J Neurol 1994, 241:354-371.
• [29]Schuff N, Ezekiel F, Gamst A, Amend D, Capizzano A, Maudsley AA, Weiner MW: Region and tissue differences of metabolites in normally aged brain using 1 H magnetic resonance spectroscopic imaging. Magn Reson Med 2001, 45:899-907.
• [30]Ferguson KJ, MacLullich AM, Marshall I, Deary IJ, Starr JM, Seckl JR, Wardlaw JM: Magnetic resonance spectroscopy and cognitive function in healthy elderly men. Brain 2002, 125:2743-2749.
• [31]William SR: In vivo proton spectroscopy: experimental aspects and potential. In NMR basic principles and progress. Volume 28. Edited by Rudin M. Berlin: Springer; 1992:55-71.
• [32]Seitz D, Widmann U, Seeger U, Nagele T, Klose U, Mann K, Grodd W: Localized proton magnetic resonance spectroscopy of the cerebellum in detoxifying alcoholics. Alcohol Clin Exp Res 1999, 23:158-163.
• [33]Parks MH, Dawant BM, Riddle WR, Hartmann SL, Dietrich MS, Nickel MK, Price RR, Martin PR: Longitudinal brain metabolic characterization of chronic alcoholics with proton magnetic resonance spectroscopy. Alcohol Clin Exp Res 2002, 26:1368-1380.
• [34]Modi S, Bhattacharya M, Kumar P, Deshpande SN, Tripathi RP, Khushu S: Brain metabolite changes in alcoholism: localized proton magnetic resonance spectroscopy study of the occipital lobe. Eur J Radiol 2011, 79:96-100.
• [35]Gazdzinski S, Durazzo TC, Yeh PH, Hardin D, Banys P, Meyerhoff DJ: Chronic cigarette smoking modulates injury and short-term recovery of the medial temporal lobe in alcoholics. Psychiat Res-Neuroim 2008, 162:133-145.
• [36]Bendszus M, Weijers HG, Wiesbeck G, Warmuth-Metz M, Bartsch AJ, Engels S, Boning J, Solymosi L: Sequential MR imaging and proton MR spectroscopy in patients who underwent recent detoxification for chronic alcoholism: correlation with clinical and neuropsychological data. Am J Neuroradiol 2001, 22:1926-1932.
• [37]Jagannathan NR, Desai NG, Raghunathan P: Brain metabolite changes in alcoholism: An in vivo proton magnetic resonance spectroscopy (MRS) study. Magn Reson Imaging 1996, 14:553-557.
• [38]Vik PW, Cellucci T, Jarchow A, Hedt J: Cognitive impairment in substance abuse. Psychiatr Clin North Am 2004, 27:97-109.
• [39]Tan HY, Chen Q, Sust S, Buckholtz JW, Meyers JD, Egan MF, Mattay VS, Meyer-Lindenberg A, Weinberger DR, Callicott JH: Epistasis between catechol-O-methyltransferase and type II metabotropic glutamate receptor 3 genes on workingmemory brain function. Proc Natl Acad Sci USA 2007, 104:12536-12541.
• [40]Baune BT, Suslow T, Beśte C, Birosova E, Domschke K, Sehlmeyer C, Konrad C: Association between genetic variants of the metabotropic glutamate receptor 3 (GRM3) and cognitive set shifting in healthy individuals. Genes Brain Behav 2010, 9:459-466.
• [41]Mössner R, Schuhmacher A, Schulze-Rauschenbach S, Kühn KU, Rujescu D, Rietschel M, Zobel A, Franke P, Wölwer W, Gaebel W, Häfner H, Wagner M, Maier W: Further evidence for a functional role of the glutamate receptor gene GRM3 in schizophrenia. Eur Neuropsychopharmacol 2008, 18:768-772.